DCM
PRAH

Delpha Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Delpha Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-246
Closed -$22K – 1468
2017
Q4 		$22K Buy
+246
New +$20.5K 0.02% 740

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Delpha Capital Management's PRAH Position: Q1 2018 in Review

Delpha Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2018, closing a stake of 246 shares — an estimated $22K sold.

Delpha Capital Management first reported a position in PRAH in Q4 2017 and held it in 1 quarter. The position peaked at $22K in Q4 2017. 278 funds tracked by Wall St. Rank hold PRAH as of Q1 2018.

  • Delpha Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 246 PRA Health Sciences, Inc. shares in Q1 2018, an estimated $22K.
  • Delpha Capital Management first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's PRA Health Sciences, Inc. position peaked at $22K in Q4 2017.
  • 278 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.